Literature DB >> 7115620

Evaluation of the supertransfusion regimen in homozygous beta-thalassaemia children.

G Masera, S Terzoli, A Avanzini, G Fontanelli, R A Mauri, G Piacentini, M Ferrari.   

Abstract

The maintenance of physiological levels of haemoglobin is beneficial in the management of patients with thalassaemia major since it leads to better tissue oxygenation, reduction of blood volume, and reduced intestinal absorption of iron. We have studied 11 patients with thalassaemia major while treating them for 4-12 months with a standard transfusion regimen (mean pre-transfusion Hb 10.2 g/dl) and then for a second period of 7-18 months with a supertransfusion regimen (mean pre-transfusion Hb 12.3 g/dl). Blood consumption was 16.71 +/- 2.0 ml/kg/month in the first period; it rose to 20.30 +/- 3.5 ml/kg/month in the first 5 months of the second period, and then returned to the values of the first period (16.53 +/0 2.0 ml/kg/month). There were no significant differences in blood consumption between the two transfusion regimens, after the 5-month equilibration period.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7115620     DOI: 10.1111/j.1365-2141.1982.tb03867.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Transfusion of neocytes concentrate/pooled neocytes in β-thalassemic patients.

Authors:  Dharmesh Chandra Sharma; Sunita Rai; Navneet Agarwal; Satya Sao; Ajay Gaur; Rahul Sapra
Journal:  Indian J Hematol Blood Transfus       Date:  2009-01-11       Impact factor: 0.900

2.  Management of thalassaemia major.

Authors:  B Modell; M Petrou
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

Review 3.  The transfusion management of beta thalassemia in the United States.

Authors:  Ashutosh Lal; Trisha Wong; Siobán Keel; Monica Pagano; Jong Chung; Aditi Kamdar; Latha Rao; Alan Ikeda; Geetha Puthenveetil; Sanjay Shah; Jennifer Yu; Elliott Vichinsky
Journal:  Transfusion       Date:  2021-08-28       Impact factor: 3.337

Review 4.  The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management.

Authors:  Athanassios Aessopos; Vasilios Berdoukas; Maria Tsironi
Journal:  Eur J Haematol       Date:  2007-12-10       Impact factor: 2.997

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.